Cardiac Implants Market Share

  • Report ID: 4111
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Cardiac Implants Market Share

North America Market Forecast

 North America industry is estimated to account for largest revenue share of 37% by 2037, attributed to increasing frequency of arrhythmias, and other heart diseases in the region. The growth of the market can be attributed majorly to the increasing frequency of arrhythmias, and other heart diseases in the region. For instance, around 12 million Americans are estimated to be diagnosed with atrial fibrillation by 2030. Further, the presence of a strong healthcare network in the region, along with the availability of a large pool of patients is also anticipated to contribute to the market growth in the region. In addition, the region's expanding healthcare industry and rising commercialization of medical equipment are also anticipated to boost market growth during the forecast period.

Asia Pacific Market Forecast

On the other hand, the Asia Pacific cardiac implants market is also attributed to holding a significant market share during the analysis period on the account of growing geriatric population in the region who are at higher risk of cardiovascular diseases. Also, the high prevalence rate of cardiovascular diseases, and other heart-related disorders among the population is expected to boost the expansion of market size in the region. Recent reports suggest that cardiovascular diseases were the leading cause of death in the Asia Pacific region taking up around 11 million lives in 2019, which is approximately 35% of the total death in the region.

Research Nester
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4111
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of cardiac implants is assessed at USD 33.53 billion.

The cardiac implants market size was over USD 29.4 billion in 2024 and is anticipated to cross USD 84.91 billion by 2037, witnessing more than 8.5% CAGR during the forecast period i.e., between 2025-2037. Higher prevalence of cardiovascular disorders and heart diseases, growing consumption of cigarettes, and increasing geriatric population will boost the market growth.

North America industry is estimated to account for largest revenue share of 37% by 2037, attributed to increasing frequency of arrhythmias, and other heart diseases in the region.

The major players in the market are Boston Scientific Corporation, BIOTRONIK SE & Co., KG, ZOLL Medical Corporation, Medtronic plc, LivaNova PLC, Abbott Laboratories, MEDICO S.R.L., Lepu Medica
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample